|
Post by TheSanDiegan on Jan 23, 2020 22:05:42 GMT -8
Not really (too much hair for AG). It does look like Nathan. And I wouldn't be surprised - I recall it had been reported he's practicing, but by himself (no contact).
|
|
|
Post by MrPerfect on Jan 23, 2020 22:30:42 GMT -8
That look like Nathan to me. I judge it by the way that he walk and his demeanor.
|
|
|
Post by cspitzcurrentaztec on Jan 23, 2020 23:19:00 GMT -8
That was, without a doubt, Nathan. I have a weird feeling that we’re going to get him back this season.
|
|
|
Post by aztech on Jan 24, 2020 0:11:23 GMT -8
Hopefully anytime before the MWC tourney. Even so I wonder if he'll only get limited minutes while he gets back into game shape. Even if he may not be 100% ready in the NCAA tourney, it's better than him not being available at all.
|
|
|
Post by Pasadenaztec on Jan 24, 2020 4:41:47 GMT -8
It definitely was not Arop....Yeah, it looked like N. Mensah to me.
|
|
|
Post by sdsu2000 on Jan 24, 2020 7:45:26 GMT -8
I would absolutely love to get Nathan back before post season. His presence in the post season is much more needed than Arop. But I hope first he gets healthy and has no more issues moving forward whenever that be.
|
|
|
Post by longtimebooster on Jan 24, 2020 7:50:25 GMT -8
I hope you guys are right. And I love your confidence. I'm still on the fence. Looked a lot like the Zapruder film to me. Was there someone on the grassy knoll? Hard to tell.
|
|
|
Post by aztecking on Jan 24, 2020 8:00:16 GMT -8
I guess we can’t be sure. But it looked more like Mensah than anyone else on the team to me.
|
|
|
Post by Den60 on Jan 24, 2020 8:11:10 GMT -8
From the hair, that has to be Nathan. He can practice but reports are he is on blood thinners so no contact.
|
|
|
Post by couldashoulda on Jan 24, 2020 8:11:13 GMT -8
Mensah, no doubt in my mind.
|
|
|
Post by The Flying Dutchman on Jan 24, 2020 8:25:58 GMT -8
100% Nathan
|
|
|
Post by fisher1fan on Jan 24, 2020 8:28:54 GMT -8
Are my eyes deceiving me? Is there a Nathan sighting at the 1:47 mark? does it matter?
|
|
|
Post by longtimebooster on Jan 24, 2020 8:50:09 GMT -8
Are my eyes deceiving me? Is there a Nathan sighting at the 1:47 mark? does it matter? Uh, yeah. A lot. And if I have to explain, well ...
|
|
|
Post by jcljorgenson on Jan 24, 2020 8:55:52 GMT -8
Didn't we already know Nathan was attending practices? It doesn't mean he is running hard, scrimmaging with the team or close to be 100%. In the video with the dunk, he seemed to be taking it easy.
|
|
|
Post by longtimebooster on Jan 24, 2020 8:56:00 GMT -8
I hope you guys are right. And I love your confidence. I'm still on the fence. Looked a lot like the Zapruder film to me. Was there someone on the grassy knoll? Hard to tell. OK. Upon further review ... definitely Mensah. I watched the first few times on my phone. This morning I finally watched on my big computer screen. Definitely Mensah. Very encouraging. Would be fantastic to get him back in the lineup.
|
|
|
Post by gigglyforshrigley on Jan 24, 2020 9:10:27 GMT -8
I'm no doctor but from what I understand, the concern while he's on blood thinners is that if he gets a bruise of some sort and bleeds internally, it basically won't stop bleeding which causes problems. That would indicate that it's fine for him to practice while he's on them as long as he isn't at risk of getting a bruise or being hit in any way. Therefore a 5 second clip of him doing a very light dunk by himself shouldn't indicate that any progress has been made. He can surely shoot around by himself with no issues. I don't understand what all the fuss is about
|
|
|
Post by fisher1fan on Jan 24, 2020 9:27:41 GMT -8
Uh, yeah. A lot. And if I have to explain, well ... Go for it. We know Nathan is at practice. I literally saw him leave practice in workout gear prior to a game. He is on the team. A soft dunk is not interesting. Please explain what is interesting because I am probably not the only one missing the hype.
|
|
|
Post by docmm on Jan 24, 2020 9:37:58 GMT -8
What's "interesting" is that for the first time, Dutcher has suggested that it's "possible" he may be able to come back this season. It takes 3-4 days for the affects of blood thinners to disappear so if the embolism is shrinking, Doctors could be able to give an informed opinion about the rate and eventual disappearance of it. Add 4-6 days onto the end of that and he could maybe be available.
It's certainly not assured but at least there's way more hope than before. It's completely reasonable that fans would get excited about it.
|
|
|
Post by longtimebooster on Jan 24, 2020 9:43:26 GMT -8
What's "interesting" is that for the first time, Dutcher has suggested that it's "possible" he may be able to come back this season. It takes 3-4 days for the affects of blood thinners to disappear so if the embolism is shrinking, Doctors could be able to give an informed opinion about the rate and eventual disappearance of it. Add 4-6 days onto the end of that and he could maybe be available. It's certainly not assured but at least there's way more hope than before. It's completely reasonable that fans would get excited about it. And it's a heck of a lot more promising than what I've seen from Nathan during the past couple of home games. He looked completely dejected and disengaged. During the Nevada game, he stood at the back of each time out huddle with his hoodie pulled up over his head, his hands in his pockets and his eyes staring at his feet. He looked like his dog had just died. So, yeah, this is an improvement.
|
|
|
Post by longtimebooster on Jan 24, 2020 9:48:26 GMT -8
Everything you wanted to know about blood clots in elite athletes: www.acc.org/latest-in-cardiology/articles/2016/10/19/15/13/athletes-and-anticoagulationCombined with thoughtful timing of dosing and careful judgment, and after the initial period of treatment for acute VTE is complete, this allows for a promising scenario: with expert medical guidance, an athlete can schedule medication dosing to maximize therapeutic time while allowing plasma drug levels to fall below an acceptable threshold before sports participation. Therapy is then promptly re-initiated once risk for trauma or bleeding sufficiently normalizes. Individualized treatment could allow for participation in contact sports while requiring anticoagulation, if desired by the athlete. Potential benefit is most pronounced for elite athletes, as financial and competitive stakes are often high. Compared to complete removal from contact sports, the risk for recurrent VTE and bleeding is likely higher if an athlete participates utilizing an individualized intermittent anticoagulation regimen. All athletic activity and medical treatment comes with risk. However, with appropriate management the absolute risk increase can be kept low. The core ethical principle of patient autonomy mandates that we should review reasonable options with an athlete and allow him/her to be a major participant in management decisions factoring in the level of risk he/she is willing to accept. Implementation of an individualized intermittent anticoagulation program is labor-intensive. Completion of personalized PK/PD studies is not practical in the general population, but for professional athletes with adequate resources, the benefit-cost ratio may be favorable. More PK/PD studies are needed to allow even safer and more evidence-based treatment plans. Physical characteristics of elite athletes often differ from the general population (e.g., extreme height), and more knowledge is needed regarding how these differences affect VTE risk and DOAC efficacy and metabolism. A registry of elite athletes requiring anticoagulation therapy could help. We propose that athletes do not necessarily need to be prevented from competing in contact sports while being anticoagulated. With DOACs now available, after obtaining PK/PD data for a specific athlete, an individualized treatment plan can be developed to allow for participation with only a small increase in risk. The athlete, with expert medical guidance, should be allowed to decide whether the benefits in his/her specific circumstances outweigh the risk.
|
|